On Invalid Date, Aeterna Zentaris (NASDAQ: AEZS) reported Q1 2023 earnings per share (EPS) of -$0.88, up 62.96% year over year. Total Aeterna Zentaris earnings for the quarter were -$4.26 million. In the same quarter last year, Aeterna Zentaris's earnings per share (EPS) was -$0.54.
As of Q2 2023, Aeterna Zentaris's earnings has grown year over year. Aeterna Zentaris's earnings in the past year totalled -$24.34 million.
What is AEZS's earnings date?
Aeterna Zentaris's earnings date is Invalid Date. Add AEZS to your watchlist to be reminded of AEZS's next earnings announcement.
What was AEZS's revenue last quarter?
On Invalid Date, Aeterna Zentaris (NASDAQ: AEZS) reported Q1 2023 revenue of $2.13 million up 40.28% year over year. In the same quarter last year, Aeterna Zentaris's revenue was $1.52 million.
What was AEZS's revenue growth in the past year?
As of Q2 2023, Aeterna Zentaris's revenue has grown 22.35% year over year. This is 47.42 percentage points lower than the US Biotechnology industry revenue growth rate of 69.78%. Aeterna Zentaris's revenue in the past year totalled $6.25 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.